SAPPHIRE™ II PRO
PTCA balloon. Coronary dilation catheter REPRESENTATIVE Ronald Lindgreen Product Specialist Cardiologyronald@angiocare.nl+31 611565663
Showing 65–78 of 78 results
-
-
SAPPHIRE™ II PRO CTO
CTO balloon. Coronary dilation catheter REPRESENTATIVE Frank Broers Sales Director Cardiologyfrank@angiocare.nl+31 653597840
-
SCOREFLEX™
Scoring balloon. Coronary dilation catheter REPRESENTATIVE Frank Broers Sales Director Cardiologyfrank@angiocare.nl+31 653597840
-
SCOREFLEX™ NC
Non-compliant scoring balloon. Coronary dilation catheter REPRESENTATIVE Frank Broers Sales Director Cardiologyfrank@angiocare.nl+31 653597840
-
SPARTAN CUBE
RAPID DNA RESULTS. Traditional lab-based DNA tests can take days to weeks for results. In contrast, the Spartan Cube goes from sample to result in less than 1 hour. Finally, you can get DNA results whenever and wherever you need them. BREAKTHROUGH DESIGN. If Apple made a personal DNA testing product, it might look something…
-
-
-
STEEREASE™ INTRODUCER
ASD closure device REPRESENTATIVE Steven schumn Product Specialist Cardiologysteven@angiocare.nl+31 615394419
-
TRANSSEPTAL NEEDLE & SHEATHS
Transseptal needle & sheath REPRESENTATIVE Alexander de Vries Director Commercial Operationsinfo@angiocare.nl
-
TRANSSEPTAL NEEDLE AND SHEATHS
Transseptal needle & sheath REPRESENTATIVE Steven Schumn Product Specialist Cardiologysteven@angiocare.nl+31 615394419
-
TRICVALVE®
TricValve® – Transcatheter Bicaval Valves System is a system of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux. The prostheses are implanted percutaneously into the superior and inferior vena cava without disturbing the native tricuspid valve. It is especially intended for use for patients at extreme…
-
-
VIVO 2
VIVO is intended for acquisition, analysis, display and storage of cardiac electrophysiological data and maps for analysis by a physician. VIVO is intended to be used as a pre-procedure planning tool for patients with structurally normal hearts undergoing ablation treatment for idiopathic ventricular arrhythmias. In clinical trials, VIVO was shown to be 100% (95% CI:…
-
